Akero Therapeutics, Inc. (AKRO) Ownership

$46.10

south_east
-$0.31 (-0.67%)
Day's range
$46.06
Day's range
$46.87

Akero Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 11/14/2025 6.28 M $298.24 M   -6.80% 7.69%
GENERAL ATLANTIC, L.P. 11/13/2025 5.73 M $272.25 M   0.00% 7.02%
BLACKROCK, INC. 11/12/2025 5.70 M $270.76 M   -1.33% 6.98%
RTW INVESTMENTS, LP 11/14/2025 5.48 M $260.07 M   0.00% 6.70%
VANGUARD GROUP INC 11/07/2025 4.53 M $214.94 M   -0.06% 5.54%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 4.25 M $201.88 M   24.69% 5.20%
DEEP TRACK CAPITAL, LP 11/14/2025 4.00 M $189.97 M   31.50% 4.90%
AVORO CAPITAL ADVISORS LLC 11/14/2025 3.96 M $187.81 M   13.02% 4.84%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 3.81 M $180.89 M   -15.51% 4.66%
STATE STREET CORP 11/14/2025 3.41 M $162.11 M   24.36% 4.18%
BELLEVUE GROUP AG 11/14/2025 2.39 M $113.44 M   20.35% 2.92%
ALKEON CAPITAL MANAGEMENT LLC 11/14/2025 1.85 M $87.88 M   0.00% 2.26%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.79 M $84.79 M   3.67% 2.19%
ALLIANCEBERNSTEIN L.P. 11/14/2025 1.69 M $80.22 M   9.99% 2.07%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 1.66 M $78.98 M   -38.64% 2.04%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.30 M $61.60 M   -1.74% 1.59%
MARSHALL WACE, LLP 11/13/2025 1.22 M $57.79 M   -14.18% 1.49%
LOGOS GLOBAL MANAGEMENT LP 11/14/2025 1.20 M $56.98 M   0.00% 1.47%
PERCEPTIVE ADVISORS LLC 11/14/2025 1.14 M $53.93 M   24.01% 1.39%
FMR LLC 11/13/2025 1.08 M $51.26 M   15.85% 1.32%
POLAR CAPITAL HOLDINGS PLC 11/14/2025 1.06 M $50.27 M   100.00% 1.30%
HOLOCENE ADVISORS, LP 11/14/2025 1.06 M $50.10 M   -1.90% 1.29%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 926.44 K $44.00 M   -6.10% 1.13%
GOLDMAN SACHS GROUP INC 11/14/2025 855.77 K $40.63 M   11.76% 1.05%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 810.57 K $38.49 M   41.29% 0.99%
REDMILE GROUP, LLC 11/14/2025 747.82 K $35.51 M   -3.42% 0.92%
LONG FOCUS CAPITAL MANAGEMENT, LLC 11/14/2025 720.00 K $34.19 M   0.00% 0.88%
CITADEL ADVISORS LLC 11/14/2025 685.84 K $32.56 M   -41.37% 0.84%
AMERICAN CENTURY COMPANIES INC 11/12/2025 663.44 K $31.50 M   100.00% 0.81%
SILVERARC CAPITAL MANAGEMENT, LLC 11/12/2025 643.64 K $30.56 M   -9.83% 0.79%
WOODLINE PARTNERS LP 11/14/2025 639.60 K $30.37 M   -74.08% 0.78%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2025 626.53 K $29.75 M   -2.19% 0.77%
NORTHERN TRUST CORP 11/14/2025 626.02 K $29.72 M   -1.31% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 612.13 K $29.06 M   -0.35% 0.75%
LOOMIS SAYLES & CO L P 11/13/2025 527.18 K $25.03 M   -2.52% 0.65%
ORBIMED ADVISORS LLC 11/14/2025 526.20 K $24.98 M   149.03% 0.64%
ABRDN PLC 11/07/2025 502.91 K $23.88 M   28.43% 0.62%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 500.00 K $23.74 M   0.00% 0.61%
BARCLAYS PLC 11/12/2025 487.23 K $23.13 M   -8.66% 0.60%
WEISS ASSET MANAGEMENT LP 11/14/2025 486.00 K $23.08 M   1,603.71% 0.59%
BRAIDWELL LP 11/14/2025 475.40 K $22.57 M   100.00% 0.58%
SOFINNOVA INVESTMENTS, INC. 11/14/2025 473.63 K $22.49 M   -13.70% 0.58%
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2025 435.29 K $20.67 M   117.65% 0.53%
VIVO CAPITAL, LLC 11/14/2025 434.69 K $20.64 M   0.00% 0.53%
DEUTSCHE BANK AG\ 11/13/2025 418.98 K $19.89 M   22.51% 0.51%
VOYA INVESTMENT MANAGEMENT LLC 10/09/2025 409.54 K $19.44 M   -1.89% 0.50%
FIRST TURN MANAGEMENT, LLC 11/14/2025 397.01 K $18.85 M   246.57% 0.49%
PRINCIPAL FINANCIAL GROUP INC 11/04/2025 378.86 K $17.99 M   -2.90% 0.46%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 11/14/2025 377.15 K $17.91 M   2.77% 0.46%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/14/2025 366.78 K $17.41 M   0.00% 0.45%

Akero Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 324 institutional investors and hedge funds held shares of Akero Therapeutics, Inc.. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 6.28 M

GENERAL ATLANTIC, L.P.: 5.73 M

BlackRock, Inc.: 5.7 M

RTW INVESTMENTS, LP: 5.48 M

VANGUARD GROUP INC: 4.53 M

WELLINGTON MANAGEMENT GROUP LLP: 4.25 M

111.90% of Akero Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 106.39 M shares in the last 24 months. This purchase volume represents approximately $4.90 B in transactions.